QHSLab, Inc.

USAQ ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2015 FY2014
Revenue $2.7M $2.1M $1.4M $1.2M $1.4M $124.5K $0 $0
Cost of Revenue $880.9K $774.0K $615.4K $623.7K $743.7K $74.4K
Gross Profit $1.8M $1.4M $793.6K $619.5K $670.7K $50.1K
Gross Margin 67.3% 63.7% 56.3% 49.8% 47.4% 40.2%
Operating Expenses
Research & Development $484.9K $294.5K $214.0K $190.1K $90.9K $98.3K
SG&A Expense $439.1K $276.5K $259.1K $387.5K $454.0K $131.8K $38.1K $28.9K
Operating Income $131.2K $205.7K $-240.2K $-560.5K $-502.3K $-275.1K $-722.1K $-40.5K
Operating Margin 4.9% 9.7% -17.0% -45.1% -35.5% -220.9%
Interest Expense $237.4K $465.1K $230.5K $433.4K $246.5K $31.0K $11.5K $11.6K
Pretax Income $457.4K $-259.2K $-468.4K $-996.0K $-770.2K $-327.4K
Income Tax Expense
Net Income $457.4K $-259.2K $-468.4K $-996.0K $-770.2K $-327.4K $-722.1K $-40.5K
Net Margin 17.0% -12.2% -33.2% -80.1% -54.5% -262.9%
EPS (Basic) $0.04 $-0.03 $-0.05 $-0.11 $-0.10 $-0.05 $-0.23 $-0.04
EPS (Diluted) $0.02 $-0.03 $-0.05 $-0.11 $-0.10 $-0.05 $-0.23 $-0.04
Shares Outstanding (Basic) 11.3M 10.3M 9.4M 9.0M 7.9M 6.6M 6.0M 1.1M
Shares Outstanding (Diluted) 19.3M 10.3M 9.4M 9.0M 7.9M 6.6M 6.0M 1.1M
Dividends Per Share
← Newer Page 1 of 2 Older →